Abstract:To study further the molecular mechanisms by which glutamate and dopamine interact to regulate the functions of the basal ganglia, the effects of persistently inhibiting dopamine receptors and glutamate N-methyl-D-aspartate receptors on the density of D-1 and D-2 dopamine receptors and on the level of their transcripts were examined in mouse brain. To block dopamine receptors, mice were treated with N-ethoxycarbonyr-2-ethoxy-1,2-dihydroquinoline once daily for two and six days, or were treated with fluphenazine-N-mustard once daily for five days. To block N-methyl-D-aspartate receptors, mice were treated with dizocilpine by continuous infusion with osmotic mini-pumps for two and six days. The density of D-1 and D-2 dopamine receptors was measured by receptor autoradiography, and the lever of D-1 and D-2 dopamine receptor messenger RNA was measured by in situ hybridization histochemistry. The results showed that N-ethoxycarbonyl-2-ethoxy-1,2-dihydroquinoline blocked about 90% of both D-1 and D-2 dopamine receptors, but had no significant effect on the lever of either D-1 or D-2 dopamine receptor messenger RNA. Fluphenazine-N-mustard, which was as effective as N-ethoxycarbonyl-2-ethoxy-1,2-dihydroquinoline in blocking D-2 dopamine receptors but had little effect on D-1 dopamine receptors, also had no significant effect on the level of D-1 and D-2 dopamine receptor messenger RNAs. By contrast, continuously infusing dizocilpine significantly decreased the levels of D-1 dopamine receptor messenger RNA in striatum, nucleus accumbens and olfactory tubercle. Dizocilpine also caused small decreases in the density of D-2 dopamine receptors, but only in posterior striatum was this decrease statistically significant. Dizocilpine slightly and transiently decreased the levels of D-1 dopamine receptor messenger RNA in striatum but had no significant effect on the density of D-1 dopamine receptors in any region examined.This study demonstrates that persistent blockade of D-1, and D-2 dopamine receptors has relatively little effect on the levels of D-1 and D-2 dopamine receptor messenger RNA, but that blockade of N-methyl-D-aspartate receptors produces a rapid and profound decrease in the levels of D-2 dopamine receptor messenger RNA and a smaller decrease in the density of D-2 dopamine receptors. These results suggest that N-methyl-D-aspartate receptors play an important role in the expression of D-2 dopamine receptors in basal ganglia.

Lesions Of Mouse Striatum Induced By 6-Hydroxydopamine Differentially Alter The Density, Rate Of Synthesis, And Level Of Gene-Expression Of D-1 And D-2 Dopamine-Receptors

Neuronal Localization and Modulation of the D2 Dopamine Receptor Mrna in Brain of Normal Mice and Mice Lesioned with 6-Hydroxydopamine

Changes in surface expression of N-methyl-D-aspartate receptors in the striatum in a rat model of Parkinson's disease.

Dopamine D2L Receptor Deficiency Alters Neuronal Excitability and Spine Formation in Mouse Striatum

In Vivo Administration of an Oligodeoxynucleotide Antisense to the D2 Dopamine Receptor Messenger RNA Inhibits D2 Dopamine Receptor-Mediated Behavior and the Expression of D2 Dopamine Receptors in Mouse Striatum.

Comparative Effects of Acute or Chronic Administration of Levodopa to 6-OHDA-lesioned Rats on the Expression and Phosphorylation of N -methyl- d -aspartate Receptor NR1 Subunits in the Striatum

D-2 Dopamine-Receptor Messenger-Rna Is Altered To A Greater Extent By Blockade Of Glutamate Receptors Than By Blockade Of Dopamine-Receptors

Dissociable Effects of Dopamine on Neuronal Firing Rate and Synchrony in the Dorsal Striatum

Dopamine receptor blockade increases dopamine D2 receptor and glutamic acid decarboxylase mRNAs in mouse substantia nigra.

Unilateral Lesion of the Nigrostriatal Pathway Induces an Increase of Neuronal Firing of the Midbrain Raphe Nuclei 5-HT Neurons and a Decrease of Their Response to 5-HT(1A) Receptor Stimulation in the Rat.

Dopamine-Receptor Blockade Increases Dopamine D-2 Receptor And Glutamic-Acid Decarboxylase Messenger-Rnas In Mouse Substantia-Nigra

Changes in Subcellular Distribution and Phosphorylation of GluR1 in Lesioned Striatum of 6-Hydroxydopamine-Lesioned and l -dopa-Treated Rats

Changes In Suhcellular Distribution And Phosphorylation Of Glur1 In Lesioned Striatum Of 6-Hydroxydopamine-Lesioned And L-Dopa-Treated Rats

Effects of Different Doses of L -Dopa on Rotational Behavior and Amounts of Cells Expressing D2 Receptors in Hemiparkinsonian Rats

Studies on Reaction of Spinal D1 and D2 Receptor Positive Neurons after 6-OHDA Lesion in Rats

Effects of L-dopa on Cells Expressing D2 Receptors and Level of Dopamine Transmitter in Hemiparkinsonian Rats

Alterations In Dopamine Neurotransmission Produced By Genetic Knockouts Of Dopamine D1 Receptors

A Comparative Study for Striatal-Direct and -Indirect Pathway Neurons to DA Depletion-Induced Lesion in a PD Rat Model.

Nmda Receptor Regulation of Levodopa-Induced Behavior and Changes in Striatal G Protein-Coupled Receptor Kinase 6 and Beta-Arrestin-1 Expression in Parkinsonian Rats

NMDA receptor remodeling and nNOS activation in mice after unilateral striatal injury with 6-OHDA

Differential effects of activating D1 and D2 receptors on electrophysiology of neostriatal neurons in a rat model of Parkinson's disease induced by paraquat and maneb.